Dear Editor,
I read with keen interest the review by Gopal et al. in the journal.[1] I am grateful for their great review. However, I would like to make some comments.
First, there are recent reports that demonstrate the superiority of quadruple or triple immunosupression versus traditional approach in terms of efficacy and safety.[2] This positive outcome is mainly related to the use of tacrolimus as the cornerstone within the immunosuppressive treatment.[3]
Second, in areas where Chagas disease is endemic, with migratory flows, reactivation should be considered when the donor has Latin-American origin, nowadays this complication has been recognized in USA and Europe.[4–5]
Third, the authors missed the important issue that transplant recipients may develop severe infection with Streptococcus pneumoniae, even in the early postransplant period.[6] Vaccination has been recommended in heart, renal and liver recipients. Available vaccines are the 23-valent polysaccharide and the hepta- and decavalent protein conjugate.[7]
References
- 1.Gopal PB, Kapoor D, Raya R, Subrahmanyam M, Juneja D, Sukanya B. Critical care issues in adult liver transplantation. Indian J Crit Care Med. 2009;13:113–9. doi: 10.4103/0972-5229.58535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Lu AW, Zheng SS, Wu J, Liang TB, Wang WL, Shen Y, et al. Dual, triple, and quadruple oral tacrolimus-based immunosuppression regimens after orthotopic liver transplantation: a randomised comparative study of regimens. Zhonghua Yi Xue Za Zhi. 2006;86:3389–92. [PubMed] [Google Scholar]
- 3.Jonas S, Neuhaus R, Junge G, Klupp J, Theruvat T, Langrehr JM, et al. Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-up. Int Immunopharmacol. 2005;5:125–8. doi: 10.1016/j.intimp.2004.09.014. [DOI] [PubMed] [Google Scholar]
- 4.Souza FF, Castro-E-Silva O, Marin Neto JA, Sankarankutty AK, Teixeira AC, Martinelli AL, et al. Acute chagasic myocardiopathy after orthotopic liver transplantation with donor and recipient serologically negative for Trypanosoma cruzi: a case report. Transplant Proc. 2008;40:875–8. doi: 10.1016/j.transproceed.2008.02.032. [DOI] [PubMed] [Google Scholar]
- 5.D’Albuquerque LA, Gonzalez AM, Filho HL, Copstein JL, Larrea FI, Mansero JM, et al. Liver transplantation from deceased donors serologically positive for Chagas disease. Am J Transplant. 2007;7:680–4. doi: 10.1111/j.1600-6143.2007.01663.x. [DOI] [PubMed] [Google Scholar]
- 6.Engelhard D, Cordonnier C, Shaw PJ, Parkalli T, Guenther C, Martino R, et al. Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey. Br J Haematol. 2002;117:444–50. doi: 10.1046/j.1365-2141.2002.03457.x. [DOI] [PubMed] [Google Scholar]
- 7.Duchini A, Goss JA, Karpen S, Pockros PJ. Vaccinations for Adult Solid-Organ Transplant Recipients: Current Recommendations and Protocols. Clin Microbiol Rev. 2003;16:357–64. doi: 10.1128/CMR.16.3.357-364.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]